BELZUTIFAN | BELZUTIFAN | ATC L01XX74
ANTINEOPLASTIC TREATMENT OF HIPPEL-LINDAU (VHL) DISEASE INHIBITOR OF HYPOXIA-INDUCIBLE FACTOR-2 ALPHA (HIF-2A) TRANSCRIPTION FACTOR | ORAL | Cmax 3.4 MICROMOLAR Tmax 1.5 HOUR VD 130 LITER PPB 45 PERCENT Cl 7.3 LITER / HOUR HT 14 HOUR SOLUBILITY INSOLUBLE IN WATER | HYPOXIA-INDUCIBLE FACTOR-2 ALPHA | More at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |